Paul T. King

Adaptive immunity to nontypeable Haemophilus influenzae.

Characterisation of the onset and presenting clinical features of adult bronchiectasis.

Outcome in adult bronchiectasis.

Microbiologic follow-up study in adult bronchiectasis.

Management of bronchiectasis and chronic suppurative lung disease in indigenous children and adults from rural and remote Australian communities.

Phenotypes of adult bronchiectasis: onset of productive cough in childhood and adulthood.

The pathophysiology of bronchiectasis.

Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand.

Lung diffusing capacity in adult bronchiectasis: a longitudinal study.

Pathogenesis of bronchiectasis.

Use of antibiotics in bronchiectasis.

NOX2β: A novel splice variant of NOX2 that regulates NADPH oxidase activity in macrophages.

Lung T-cell responses to nontypeable Haemophilus influenzae in patients with chronic obstructive pulmonary disease.

Chest pain and exacerbations of bronchiectasis.

Haemophilus influenzae and the lung (Haemophilus and the lung).

Reply: To PMID 23142009.

Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand Thoracic Society of Australia and New Zealand guidelines.

Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand Thoracic Society of Australia and New Zealand guidelines.

Nontypeable Haemophilus influenzae induces sustained lung oxidative stress and protease expression.

The Lung Immune Response to Nontypeable Haemophilus influenzae (Lung Immunity to NTHi).

Inflammation in chronic obstructive pulmonary disease and its role in cardiovascular disease and lung cancer.

The lung immune response to bacteria in chronic obstructive pulmonary disease.

Cardiac dysfunction during exacerbations of chronic obstructive pulmonary disease.

Bacteria in COPD; their potential role and treatment.

Therapeutic Targeting of the IL-6 Trans-Signaling/Mechanistic Target of Rapamycin Complex 1 Axis in Pulmonary Emphysema.

Opportunities and challenges of non-CF bronchiectasis.

Endosomal NOX2 oxidase exacerbates virus pathogenicity and is a target for antiviral therapy.

Deoxyribonuclease 1 reduces pathogenic effects of cigarette smoke exposure in the lung.

Emerging role of viral and bacterial co-infection in early childhood.

The Role of the Immune Response in the Pathogenesis of Bronchiectasis.

C-reactive protein levels in acute respiratory exacerbations of cystic fibrosis.

Pseudomonas aeruginosa cross-infection: Is this important in bronchiectasis and COPD?

Response.

Prevalence of reduced carbon monoxide transfer factor in smokers with normal spirometry.

Late presentation of organising pneumonia in COVID-19.

Phagocyte extracellular traps in children with neutrophilic airway inflammation.

The 1918 influenza and COVID-19 pandemics: The effect of age on outcomes.